These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 994538)

  • 41. The mechanism of myocardial protection from ischemic arrest by intracoronary tetrodotoxin administration.
    Tyers GF; Todd GJ; Neely JR; Waldhausen JA
    J Thorac Cardiovasc Surg; 1975 Feb; 69(2):190-5. PubMed ID: 1113537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intermittent aortic cross-clamping versus St. Thomas' Hospital cardioplegia in extensive aorta-coronary bypass grafting. A randomized clinical study.
    Flameng W; Van der Vusse GJ; De Meyere R; Borgers M; Sergeant P; Vander Meersch E; Geboers J; Suy R
    J Thorac Cardiovasc Surg; 1984 Aug; 88(2):164-73. PubMed ID: 6379305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [-Myocardial protection by preconditioning. Experimental and clinical significance-].
    Strasser R; Vogt A; Schaper W
    Z Kardiol; 1996 Feb; 85(2):79-89. PubMed ID: 8650986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reperfusion of inflow-limited myocardium following hypothermic potassium-induced cardioplegia.
    Chitwood WR; Hill RC; Wechsler AS
    J Thorac Cardiovasc Surg; 1984 Jul; 88(1):49-56. PubMed ID: 6738102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Experimental studies of coronary perfusion with cold Ringer's lactate solution to protect the hypertrophied left ventricles for 2 hours ischemic arrest (author's transl)].
    Ohori K; Abe T
    Nihon Kyobu Geka Gakkai Zasshi; 1977 Dec; 25(12):1610-21. PubMed ID: 148481
    [No Abstract]   [Full Text] [Related]  

  • 46. [Efficacy of myocardial protection with various cardioplegia infusates: studies the isolated rat heart].
    Morimoto K; Naito A; Inoue T; Miya T; Onoe Y
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):459-61. PubMed ID: 469306
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of hyperglycemia on cardiac tolerance to normothermic anoxia arrest during cardiopulmonary bypass in dogs.
    Petracek MR; Stevenson RL; Lewis KB; Wright JR; Love JW
    Ann Surg; 1970 Dec; 172(6):1069-75. PubMed ID: 5496477
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical and experimental effects of pulsatile perfusion on the myocardium after global ischemia].
    Wake K
    Nihon Kyobu Geka Gakkai Zasshi; 1985 Nov; 33(11):2074-87. PubMed ID: 4093670
    [No Abstract]   [Full Text] [Related]  

  • 49. Myocardial protection by coronary washout during global ischemic cardiac arrest.
    LaRaia PJ; Bing OH; Gaasch WH; Levine FH; Pine MB; Spadaro J; Crawford FD; Weintraub RM
    J Surg Res; 1981 Sep; 31(3):179-87. PubMed ID: 7278229
    [No Abstract]   [Full Text] [Related]  

  • 50. Myocardial protection era: from valve surgery to heart transplantation.
    Salerno TA
    Artif Organs; 2012 Nov; 36(11):939-42. PubMed ID: 23121201
    [No Abstract]   [Full Text] [Related]  

  • 51. Experimental evaluation of coronary infusates in dogs.
    Raju S; Gibson WJ; Heath B; Lockhart V; Conn H
    Arch Surg; 1975 Nov; 110(11):1374-82. PubMed ID: 1191032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [An attempt to monitor parameters of glycolysis and degradation of nucleotides in patients during heart surgery].
    Pechán I; Cornák V; Barta E; Rendeková V; Halcák L; Verchovodko P
    Cesk Fysiol; 1989; 38(6):520-2. PubMed ID: 2630056
    [No Abstract]   [Full Text] [Related]  

  • 53. Myocardial protection in cardiac surgery: a historical review from the beginning to the current topics.
    Yamamoto H; Yamamoto F
    Gen Thorac Cardiovasc Surg; 2013 Sep; 61(9):485-96. PubMed ID: 23877427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myocardial protection: the rebirth of potassium-based cardioplegia.
    Shiroishi MS
    Tex Heart Inst J; 1999; 26(1):71-86. PubMed ID: 10217472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myocardial protection during cardioplegia in open-heart surgery: a review.
    Chatrath RR; Kaul TK; Walker DR
    Can Anaesth Soc J; 1980 Jul; 27(4):381-8. PubMed ID: 6996794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myocardial protection during bypass and arrest. A possible hazard with lactate-containing infusates.
    Hearse DJ; Stewart DA; Braimbridge MV
    J Thorac Cardiovasc Surg; 1976 Dec; 72(6):880-4. PubMed ID: 994538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myocardial protection during ischemic cardiac arrest. Possible deleterious effects of glucose and mannitol in coronary infusates.
    Hearse DJ; Stewart DA; Braimbridge MV
    J Thorac Cardiovasc Surg; 1978 Jul; 76(1):16-23. PubMed ID: 661362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myocardial protection during ischemic cardiac arrest. A possible hazard with calcium-free cardioplegic infusates.
    Jynge P; Hearse DJ; Braimbridge MV
    J Thorac Cardiovasc Surg; 1977 Jun; 73(6):848-55. PubMed ID: 859352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myocardial protection during ischemic cardiac arrest. The importance of magnesium in cardioplegic infusates.
    Hearse DJ; Stewart DA; Braimbridge MV
    J Thorac Cardiovasc Surg; 1978 Jun; 75(6):877-85. PubMed ID: 661356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection of the ischemic myocardium. Ultrastructural, enzymatic, and functional assessment of the efficacy of various cardioplegic infusates.
    Jynge P; Hearse DJ; de Leiris J; Feuvray D; Braimbridge MV
    J Thorac Cardiovasc Surg; 1978 Jul; 76(1):2-15. PubMed ID: 661363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.